PHARMACEUTICAL IP

  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Events & Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our Offering
    • Fractional in-house
    • Start-ups
    • Established pharma
    • International IP counsel
    • Investors
    • Due diligence
    • Evolve AI
  • Fractional in-house
  • Sectors
    • Pharmaceuticals
    • Biotechnology
    • Biologics
    • Cell & gene therapies
    • AI drug discovery
    • Chemistry
  • Evolve Insights
    • Articles
    • Events & Webinars
    • Subscribe
  • About us
    • Our team
    • Join us
    • Contact us
  • Our offering
  • Fractional in-house
  • Sectors
  • Evolve Insights
  • Our team
  • Join us
  • Our offering
  • Fractional in-house
  • Sectors
  • Evolve Insights
  • Our team
  • Join us

Evolve AI

AI tools for IP that are expert-led, pharma-specific and client-centric

AI is one tool in our toolbox for helping us with our core mission of assisting pharmaceutical companies in bringing innovative medicines to market to give hope to patients.

At Evolve, we are focused on using AI in a way that will truly add value to our clients. We have developed our own AI tools and workflows that are tailored to the unique requirements of pharmaceutical and biotech IP. As a specialised and agile firm devoted to pharmaceutical and biotechnology, we possess deep domain knowledge of life science patents and practical experience developing our own in-house AI solutions. We tailor our AI workflows and tools to the needs of our clients and the unique challenges of the pharmaceutical sector.

At Evolve, we have therefore chosen to build our own AI solutions as opposed to rely on third-party software providers providing generalised off-the-shelf solutions. We strongly believe that AI solutions for the patent industry need to be expert-led and aligned with the requirements of specific technical fields.

Our clients come first

Our use of AI follows our strict professional code of conduct as patent attorneys, including maintaining the highest level of confidentiality and data security for our clients’ data. Our sophisticated workflows also ensure that all client work products generated by AI remain meticulously reviewed, interpreted, and verified by a qualified patent attorney. Additionally, we will only use generative AI in connection with a client’s confidential information after establishing consent.

Learn more

If you would like to hear more about how we are leveraging AI technology to secure robust patent protection for our clients, or would like to discuss potential collaborations, please contact a member of our team. We would love to hear from you!  

Read more about how we are leveraging AI to increase value for clients on our Evolve Insights blog.

I recommend Evolve for chemical/pharma patent issues – whether prosecution or complex FTO or loss of exclusivity considerations.

I chose Evolve because they have unique expertise in pharma IP. They are friendly and knowledgeable and provide practical advice.

evolve® is a trading entity of Evolve Intellectual Property Limited. Evolve Intellectual Property Limited is regulated by the Intellectual Property Regulation Board (IPReg). Details of the UK professional rules can be found on the IPReg website

registered address: 49 Greek Street, London, England, W1D 4EG

website out of house

© 2025 All Rights Reserved

Keep in touch

Subscribe

Contact Us